Organic Chemistry

Izgu Lab_website_Home_OrgChem1_2nd_edited.png

Chemical Biology

cover art_Miyamoto_signed_edited_edited.


We work to advance biotechnology and medicine by combining organic chemistry, chemical biology, and biomaterials.

Our lab strives to maintain a collegial and inclusive environment where people treat each other with respect.


E. C. Izgu presents research for the special symposium Frontiers of Medicinal Chemistry and Chemical Biology in the American Chemical Society, Middle Atlantic Regional Meeting. Pleased to be a part of a great line-up of speakers from academia and industry, and having the opportunity to listen to many exciting talks all across chemistry.

ACS MARM image for website.png


Huseyin's collaborative work with Bryan and Rhia on probing cellular nitrosative stress receives funding from the Rutgers Center for Lipid Research. Congrats Huseyin!

Izgu lab receives a major commercialization grant through a parent National Institutes of Health’s Research Evaluation and Commercialization Hub (REACH) award from the National Heart, Lung, and Blood Institute to Rutgers. This highly competitive grant has been selected by the Rutgers HealthAdvance program, which focuses on advancing innovative technologies with translational potential. For more details check out the Departmental News and the Rutgers Research – HealthAdvance projects.

NHBLI logo.png

Bryan receives Rieman Award, given by the Department of Chemistry and Chemical Biology to recognize graduate students for excellence in undergraduate teaching. Congrats Bryan!  


Bryan's research proposal on the investigation of lipid membrane reactivity in diseased cells receives funding from the Rutgers Center for Lipid Research. Congrats Bryan! 

A highly configurable RNA-based imaging technology that Tushar is developing leads to a provisional patent. Congrats Tushar, and thanks to the Rutgers ORED and NIH for supporting this technology.

E.C. Izgu receives the NIH, National Institute of Biomedical Imaging and Bioengineering (NIBIB) Trailblazer Award. The NIH / NIBIB Trailblazer Award is a great opportunity for early-stage investigators to pursue high-impact research programs of high interest to the NIH and NIBIB at the interface of the life and physical sciences. We are thrilled to have this recognition from the NIH for our ongoing efforts in building bioorthogonal platforms to investigate aberrant metabolic pathways and how pathogenesis originates in the cell. For details and highlights, check out the Departmental News and Rutgers Newsletter, The Current.

NIH Logo.png
NIBIB Logo.png

Izgu Lab and Biological Mimetics, Inc. (BMI) join forces to combat viral pathogens that are extremely potent and easily transmissible. BMI is a leading biopharma company that specializes on development of vaccines against severe viruses that affect humans

The Yildirim et al. (Bob Kingston Lab, HMS) collaborative work titled "S-Phase enriched non-coding RNAs regulate gene expression and cell cycle progression" has been published in Cell Reports.

The lab receives Research Grants Program Award from the New Jersey Health Foundation, which will support our studies on the prevention and eradication of biofilms. 

NJHF Logo.jpg

Bryan's research proposal on the investigation of lipid membrane reactivity in diseased cells receives funding from the Rutgers Center for Lipid Research. Congrats Bryan! 


The next-generation material surface functionalization technology that Zhaojun (John) Jia is developing leads to a provisional patent. Congrats John, and thanks to the Rutgers ORED for supporting our technology. Update: PCT application filed in Dec 2020.

A team of Rutgers faculty including E.C. Izgu receives funding from the Chancellor's Office of Rutgers for the in vitro design and in vivo implementation of synthetic cells.

The lab receives the Charles and Johanna Busch Biomedical Grant Award. Thanks to the Rutgers, Office of Research and Economic Development (ORED) for supporting our research.

E.C. Izgu receives the American Cancer Society Institutional Research Grant
Early Investigator Award.
This award is complemented with additional funds from
the Cancer Institute of New Jersey. Thanks to both ACS and CINJ for supporting our research!

Rutgers CINJ logo_Screen Shot 2019-01-22 at 2.40_edited.jpg
  • Twitter

Follow us on

LinkedIn Logo.png
© Copyright